This inventor holds 3 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Biothera Inc., Hibercell, Inc.. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Nadine Ottoson: Innovator in Immunopharmacodynamics
Introduction
Nadine Ottoson is a prominent inventor based in Lakeville, MN (US). She has made significant contributions to the field of immunopharmacodynamics, holding a total of 3 patents. Her work focuses on optimizing immunotherapy strategies and enhancing the effectiveness of treatments in the tumor microenvironment.
Latest Patents
One of her latest patents is titled "Beta glucan immunopharmacodynamics." This disclosure provides dosing strategies for soluble β-glucan immunotherapy to optimize acute immunopharmacodynamic responses. It also outlines a method for analyzing a sample from a subject to identify the appropriate dosing strategy for soluble β-glucan immunotherapy. The method includes obtaining a biological sample, analyzing it for a biomarker, and classifying the subject based on the biomarker levels.
Another significant patent is related to "β-glucan methods and compositions that affect the tumor microenvironment." This disclosure discusses the combination of soluble β-glucan and immune suppression-relieving agents. These agents promote an immunostimulatory environment, enhancing the effectiveness of anti-angiogenics and checkpoint inhibitors.
Career Highlights
Nadine has worked with notable companies such as Biothera Inc. and Hibercell, Inc. Her experience in these organizations has allowed her to develop innovative solutions in the field of immunotherapy.
Collaborations
Throughout her career, Nadine has collaborated with talented individuals, including Nandita Bose and Jeremy Graff. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Nadine Ottoson is a trailblazer in the field of immunopharmacodynamics, with a focus on optimizing immunotherapy strategies. Her innovative patents and collaborations highlight her commitment to advancing medical science.